A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide

Clinical trial NCT06758583 · COMPLETED

Trial details

NCT number: NCT06758583
Sponsor: Zealand Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2024-12-23
Primary completion: 2025-04-12
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.